- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04455334
Error-augmented Walking on Gait Performance and Brain Activities in Stroke
The Effects of Error-augmented Walking on Gait Performance and Brain Activities in Individuals With Stroke
This three-year study is proposed to document the effect and further implementation of error-augmented walking on gait performance and brain activities in individuals with stroke. Note that brain activations of post-stroke individuals during locomotion is a relatively unexplored realm. In the first year, study aims to observe the gait performance and brain activity of post-stroke and healthy participants when they walk on the split-belt treadmill, which inputs errors and causing adaptation during locomotion. Second year, study focuses on the long-term effect in aspect of brain activation and gait performance after training the post-stroke individuals with error-augmented treadmill walking. Lastly, study aim to investigate the long-term effect of practically applying the concept of error-augmented training strategy into clinical physical therapy.
The first-year study is a cross-sectional study to recruit post-stroke and healthy participants. Gait performance will be measured by GaitUp system and brain activity during each walking trails will be measured concurrently by functional near infrared spectroscopy (fNIRS). Cadence, stride time, stride length and swing cycle are the gait parameters that will be recorded. Also, symmetry ratio and variability of temporal and spatial parameters will also be calculated. Brain area of interest in this study will be bilateral premotor cortex (PMC), supplementary motor area (SMA) and medial part of primary motor cortex (M1). Study will run one-way analysis of variance (ANOVA) with repeated measures and, if needed, Tukey post hoc test will be used to document the within group and between group differences with p<.05.
The second year and third year study are single-blinded (assessor), randomized controlled trials. In the second year, study will recruit and randomize post-stroke participants into one of the two training groups, error-augmented treadmill training group (ETT group) and active control group (AC group). In ETT group, participants will practice split-belt treadmill walking. And participants in AC group will received traditional treadmill walking. The training duration will be 40 minutes per session, 3 sessions per week for a total of 4 weeks for every group. There will be three evaluations, chronologically, on one day before intervention, one day after completion of intervention and one month after completion of intervention. Gait performance, brain activity, dynamic gait index and sensorimotor ability of lower extremity will be documented. Two-way ANOVA and Tukey post-hoc test will be used to determine the training and follow-up effects with p< .05. During the third year, individuals with stroke will be recruited and randomized to one of the two group, error-augmented concept combined physical therapy group (EAPT group) and conventional physical therapy group (CPT group). Participants in the CPT group will receive thirty-minute conventional physical therapy each session. Instead of training on a split-belt treadmill, participants in EAPT group will receive fifteen-minute walking trainings that implement the error-augmented concept and another fifteen-minute conventional physical therapy each session. The training duration will be 40 minutes per session, 3 sessions per week for a total of 4 weeks for every group. The outcome measurements, and statistical analysis are the same as those described in the second year.
Study Overview
Status
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Yanci Liu, Ph.D
- Phone Number: 0233668135
- Email: yanciliu@ntu.edu.tw
Study Locations
-
-
-
Taipei, Taiwan
- Recruiting
- National Taiwan University Hospital
-
Contact:
- Yanci Liu, PHD
- Phone Number: 0233668135
- Email: yanciliu@ntu.edu.tw
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
The inclusion criteria of stroke participants are
- first unilateral stroke
- older than 20 years old
- medically stable
- lesion site limited in subcortical area
- having step length asymmetry (asymmetry ratio ≥ 1.08)
- ability to walk 10 meters independently without an assistive device.
The inclusion criteria of healthy participants are
- ability to walk 10 meters independently without an assistive device
- no any other neurological, psychological, or orthopedic disorders known to interfere the walking performance
- mini-mental status examination scores > 24 points
The exclusion criteria are
- Participants who are medical unstable
- cognitive impaired (mini-mental status examination scores < 24 points)
- diagnosed with other neurological, psychological, or orthopedic disorders known to interfere the participation to the study
- with the diagnosis which the contraindication includes exercise
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: healthy
year 1 study
|
NO INTERVENTION
|
Other: stroke
year 1 study
|
NO INTERVENTION
|
Active Comparator: active control group
year 2 study
|
walk on tie-belt treadmill
|
Experimental: Error-augmented treadmill training
year 2 study
|
walk on split-belt treadmill
|
Experimental: Error-augmented concept combined physical therapy group
year 3 study
|
Error-augmented concept combined physical therapy
|
Active Comparator: conventional physical therapy group
year 3 study
|
conventional physical therapy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of walking performance - Cadence
Time Frame: Change from Baseline cadence at 4 weeks
|
The unit is steps per minutes
|
Change from Baseline cadence at 4 weeks
|
Change of walking performance - Cadence
Time Frame: Change from Baseline cadence at 8 weeks
|
The unit is steps per minutes
|
Change from Baseline cadence at 8 weeks
|
Change of walking performance - stride time
Time Frame: Change from Baseline cadence at 4 weeks
|
The unit is seconds
|
Change from Baseline cadence at 4 weeks
|
Change of walking performance - stride time
Time Frame: Change from Baseline cadence at 8 weeks
|
The unit is seconds
|
Change from Baseline cadence at 8 weeks
|
Change of walking performance - stride length
Time Frame: Change from Baseline cadence at 4 weeks
|
The unit is cm
|
Change from Baseline cadence at 4 weeks
|
Change of walking performance - stride length
Time Frame: Change from Baseline cadence at 8 weeks
|
The unit is cm
|
Change from Baseline cadence at 8 weeks
|
Change of walking performance - swing cycle
Time Frame: Change from Baseline cadence at 4 weeks
|
The unit is percentage (%)
|
Change from Baseline cadence at 4 weeks
|
Change of walking performance - swing cycle
Time Frame: Change from Baseline cadence at 8 weeks
|
The unit is percentage (%)
|
Change from Baseline cadence at 8 weeks
|
Change of walking performance - symmetry ratio
Time Frame: Change from Baseline cadence at 4 weeks
|
V(larger value) / V(lesser value), V=step length(spatial) or step time(temporal)
|
Change from Baseline cadence at 4 weeks
|
Change of walking performance - symmetry ratio
Time Frame: Change from Baseline cadence at 8 weeks
|
V(larger value) / V(lesser value), V=step length(spatial) or step time(temporal)
|
Change from Baseline cadence at 8 weeks
|
Change of walking performance - variability
Time Frame: Change from Baseline cadence at 4 weeks
|
CV(coefficient of variation) = standard deviation/mean x 100% of the stride length(spatial) or stride time(temporal)
|
Change from Baseline cadence at 4 weeks
|
Change of walking performance - variability
Time Frame: Change from Baseline cadence at 8 weeks
|
CV(coefficient of variation) = standard deviation/mean x 100% of the stride length(spatial) or stride time(temporal)
|
Change from Baseline cadence at 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Brain activities over premotor cortex
Time Frame: Change from Baseline cadence at 4 weeks
|
A multichannel wearable fNIRS imaging system (NIRSport2, NIRx Medical Technologies LLC, Glen Head, NY, USA) is used to detect the hemodynamics.
|
Change from Baseline cadence at 4 weeks
|
Brain activities over premotor cortex
Time Frame: Change from Baseline cadence at 8 weeks
|
A multichannel wearable fNIRS imaging system (NIRSport2, NIRx Medical Technologies LLC, Glen Head, NY, USA) is used to detect the hemodynamics.
|
Change from Baseline cadence at 8 weeks
|
Brain activities over supplementary motor area
Time Frame: Change from Baseline cadence at 4 weeks
|
A multichannel wearable fNIRS imaging system (NIRSport2, NIRx Medical Technologies LLC, Glen Head, NY, USA) is used to detect the hemodynamics.
|
Change from Baseline cadence at 4 weeks
|
Brain activities over supplementary motor area
Time Frame: Change from Baseline cadence at 8 weeks
|
A multichannel wearable fNIRS imaging system (NIRSport2, NIRx Medical Technologies LLC, Glen Head, NY, USA) is used to detect the hemodynamics.
|
Change from Baseline cadence at 8 weeks
|
Brain activities over primary motor cortex
Time Frame: Change from Baseline cadence at 4 weeks
|
A multichannel wearable fNIRS imaging system (NIRSport2, NIRx Medical Technologies LLC, Glen Head, NY, USA) is used to detect the hemodynamics.
|
Change from Baseline cadence at 4 weeks
|
Brain activities over primary motor cortex
Time Frame: Change from Baseline cadence at 8 weeks
|
A multichannel wearable fNIRS imaging system (NIRSport2, NIRx Medical Technologies LLC, Glen Head, NY, USA) is used to detect the hemodynamics.
|
Change from Baseline cadence at 8 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dynamic Gait Index
Time Frame: Change from Baseline cadence at 4 weeks
|
Change from Baseline cadence at 4 weeks
|
|
Dynamic Gait Index
Time Frame: Change from Baseline cadence at 8 weeks
|
Change from Baseline cadence at 8 weeks
|
|
Fugl-Meyer assessment
Time Frame: Change from Baseline cadence at 4 weeks
|
Sensorimotor impairment of lower extremity
|
Change from Baseline cadence at 4 weeks
|
Fugl-Meyer assessment
Time Frame: Change from Baseline cadence at 8 weeks
|
Sensorimotor impairment of lower extremity
|
Change from Baseline cadence at 8 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Yanci Liu, Ph.D, National Taiwan University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202004042RIND
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
Clinical Trials on NO INTERVENTION
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
University of Dublin, Trinity CollegeCompleted
-
Hôpital Necker-Enfants MaladesUnknown
-
China Medical University HospitalUnknownIntention to Stay, Turnover Behavior
-
University of PittsburghCompletedChronic Low Back PainUnited States